THE PRESENT INVENTION PROVIDES PYRIMIDINONES THAT MODULATE THE ACTIVITY OF PHOSPHOINOSITIDE 3-KINASES (PI3Ks) AND ARE USEFUL IN THE TREATMENT OF DISEASES RELATED TO THE ACTIVITY OF PI3Ks INCLUDING, FOR EXAMPLE, INFLAMMATORY DISORDERS, IMMUNE-BASED DISORDERS, CANCER, AND OTHER DISEASES.